The Council reached a political agreement on a new law that would facilitate the purchase of medicines, vaccines and raw materials, while at the same time it could activate emergency funding and allow the monitoring of production facilities, in case of another health crisis.
The Council Regulation will establish a Health Crisis Council to coordinate and complete actions related to medical countermeasures at EU level. The Regulation establishes monitoring mechanisms and allows the supply and purchase of countermeasures. Defines how to activate EU FAB facilities (capacity network for vaccines and medicines) as well as emergency research.
The Health Crisis Council, which coordinates the provision and access to medical countermeasures at EU level, will be co-chaired by the Commission and the rotating presidency. Member States have also decided that the Commission should consult the Council before taking any action.
In the case of purchases of medical countermeasures and raw materials, Member States may instruct the Commission to act as the central purchasing body. When the Commission intends to conclude a contract, it must inform the participating Member States. They also have the opportunity to comment on the draft contracts – which the Commission should take into account.
Under the current political agreement, the final text (after technical adjustments) will be submitted to the Council for approval in the first months of 2022.
SOURCE: AMPE
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
